E647-3755 Screening compound: N-[3-(diethylamino)propyl]-2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)butanamide

E647-3755 Screening compound: N-[3-(diethylamino)propyl]-2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)butanamide
E647-3755 Screening compound: N-[3-(diethylamino)propyl]-2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E647-3755
N-[3-(diethylamino)propyl]-2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E647-3755

Molecular Formula

C21H33N3O2 (C21 H33 N3 O2)

Compound Name

N-[3-(diethylamino)propyl]-2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)butanamide

IUPAC name

N-[3-(diethylamino)propyl]-2-(2-oxo-2345-tetrahydro-1H-1-benzazepin-1-yl)butanamide

SMILES

CCC(C(NCCCN(CC)CC)=O)N(c1c(CCC2)cccc1)C2=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

359.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.047

Distribution Coefficient, logD

0.268

Water Solubility, LogSw

-3.35

Polar Surface Area

43.084

Acid Dissociation Constant (pKa)

15.06

Base Dissociation Constant (pKb)

10.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.90

E647-3755 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
Targets:
  • Kinases
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E647-3755 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E647-3755?
Check Price and Availability of E647-3755, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E647-3755 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E647-3755
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E647-3755
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E647-3755 available by request